n. A monoclonal antibody which is linked with yttrium-90 as the drug ibritumomab tiuxetan
Word Usage
"ZEVALIN (ibritumomab tiuxetan) is indicated for the treatment of patients with previously untreated follicular non-Hodgkin's Lymphoma (NHL), who achieve a partial or complete response to first-line chemotherapy."